Cosmetic-Drug Products Subject To FDA's OTC Labeling Final Rule
This article was originally published in The Rose Sheet
Executive Summary
FDA is not allowing an exemption for cosmetic-drugs in its final rule for standardized OTC drug labeling, announced by Vice President Gore at a March 11 ceremony. The reg is scheduled to be published in the Federal Register March 17.
You may also be interested in...
Antiperspirant OTC Labeling Flexibility Requested By CTFA
Antiperspirant labeling should be allowed to drop the "Drug Facts" heading required for OTCs because it "is unnecessary and reduces the space available for important label information," the Cosmetic, Toiletry and Fragrance Association states in an April 11 citizen petition to FDA
Antiperspirant OTC Labeling Flexibility Requested By CTFA
Antiperspirant labeling should be allowed to drop the "Drug Facts" heading required for OTCs because it "is unnecessary and reduces the space available for important label information," the Cosmetic, Toiletry and Fragrance Association states in an April 11 citizen petition to FDA
OTC Labeling Trade Dress Issue Resolved In FDA Technical Amendment
Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label reform rule published in the Jan. 3 Federal Register.